ARCHIVES

Beth Israel Suspends Enrollment In Trials Following An Audit

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Okays Agreement Between Allegheny, Pitt, Over NSABP

February 3, 1995

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

Cyramza Combination Approved In Advanced Gastric Cancer

November 28, 2014

RFA On etiology Of AIDS, Kaposi’s

June 3, 1983

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Allegations Reflect Misunderstanding, Pan Data Says

August 4, 1989